The overall cutaneous response rate was 24% (95% CI, 14%-40%) after 3 months, 46% (95%
CI, 32%-62%) after 6 months, and 79% (95% CI, 64%-98%) after 12 months. Median ePOST
severity score decreased from 5 at baseline to 3 at the last follow-up. Among a total of
31 responders, 13 achieved complete response and 18 achieved partial response as best
response during follow-up.